Bronchial Thermoplasty Catheter Market Size & Share, by End user (Hospitals, Ambulatory Surgical Centers, Specialty Clinics); Product Type; Application; Procedure Type; Distribution Channel; Patient Age Group - SWOT Analysis, Competitive Strategic Insights, Regional Trends 2026-2035

Bronchial Thermoplasty Catheter Market - Regional Analysis

North America Market Insight

The bronchial thermoplasty catheter market in North America is expected to hold the highest market share of 39% within the forecast period due to early and broad regulatory approvals, well-established reimbursement policies, high rates of severe asthma, and dense specialist infrastructure and networks of hospitals. Misperceptions regarding control of asthma and controller drugs are common in North America. The NLM April 2022 study found that 60% to 77% of the patients believed their asthma was well under control, but only 8% to 29% had clinically well-controlled asthma. The perception-reality mismatch is bringing pressure for the patients, which shows an urgent need for better long-term interventions such as bronchial thermoplasty, especially in those with refractory symptom control on treatment.

The bronchial thermoplasty catheter market in Canada is growing due to rising pulmonologists and patients awareness of its treatment for severe asthma, an increase in reimbursement coverage, an increase in hospitalization of asthma cases, and investment in respiratory care facilities. As per a report by the Government of Canada, in February 2024, in March 2023, Canada Health Transfer deductions exceeding USD 82.5 million were imposed upon provinces that allowed patient charges for medically necessary services, thus marking the first instance of enforcement under the Canada Health Act's Diagnostic Services Policy. This commitment by the Government for equitable access has a positive impact towards more adoption of bronchial thermoplasty, as out-of-pocket barriers are no longer limited, and access through public funding is enhanced.

Asthma prevalence and mortality in the population of North America (2022)

Source: NLM April 2022

Europe Market Insight

The bronchial thermoplasty catheter market in Europe is expected to hold the fastest-growing market within the forecast period due to an increasing trend in the prevalence of severe asthma across many countries, wider acceptance of interventional pulmonology procedures, support from governments, and inclusion in asthma management guidelines. According to a report by NLM in May 2025, the prevalence of asthma in most countries, such as France, Germany, Italy, Spain, and the UK, was 6.7%. Of the respondents, nearly 52.0% had mild asthma, 27.9% moderate asthma, and 20.1% severe asthma. The huge number of severe cases provides a demand for more novel treatments such as bronchial thermoplasty.

The bronchial thermoplasty catheter market in the UK is growing due to an increase in clinical evidence and the inclusion of bronchial thermoplasty in asthma treatment guidelines. Better NHS reimbursement pathways are being structured along with the community, thus raising awareness among physicians and the general public, while investments are also made into specialized respiratory centers and ambulatory surgical units. According to a report by NLM in May 2025, the UK has the highest rates of asthma prevalence at 10.4% and this increasing number of severe asthma patients fuels demand for long-term treatment options sustained by bronchial thermoplasty which is increasing the bronchial thermoplasty catheter market.

Asia Pacific Market Insight

The bronchial thermoplasty catheter market in the Asia Pacific is expected to grow steadily within the forecast period due to increasingly heavy burdens of asthma and respiratory disorders caused by urbanization, air pollution, an aging population, and healthcare expenditure. Governments across the region have taken to launching awareness campaigns and funding programs. With heavy investments in research and development, these technologies are being fostered to innovate along with catheter production so as to provide better safety and efficacy. Another way to expedite the availability of good products would be working with public health agencies and private medical device companies. There are also training courses for pulmonologists that will further ensure skilled utilization of bronchial thermoplasty procedures.

The bronchial thermoplasty catheter market in China is growing due to strong government emphasis on the growth of healthcare infrastructure, a large patient population with increasing prevalence of asthma and respiratory disorders, and rising disposable incomes and health insurance coverage. According to a report by NLM in October 2024, the total prevalence of asthma in Mainland China is 2.2% for ever asthma, 2.1% for current asthma, 14.3% for ever asthma-symptoms, and 3.0% for current asthma-symptoms. This immense burden of respiratory symptoms engenders an urgent need for effective treatment methods such as bronchial thermoplasty, thereby increasing demand in both urban and rural areas.